Tandem Diabetes Care, Inc. [NASDAQ: TNDM] stock went up by 2.43% or 1.97 points up from its previous closing price of $81.05. The stock reached $83.02 during the last trading session. During the course of the last 5 trading session in the week, TNDM share price went up during 2 out of 5 days, that way gaining +10.69% in the period of the last 7 days.
TNDM had two major price movements with the latest trading session as the price jumped to a high of $83.91, at one point touching $80.00. The latest high is set lower that the high price recorded in the period of the last 52 weeks, set at $83.91. The 52-week high currently stands at $82.59 distance from the present share price, noting recovery 79.62% after the recent low of $44.45.
Tandem Diabetes Care, Inc. [NASDAQ:TNDM]: Analyst Rating and Earnings
Its stock price has been found in the range of 44.45 to 82.59. This is compared to its latest closing price of $81.05.
Keep looking out for the next-scheduled quarterly financial results that this company is expected to put out, which is slated to occur on Mon 24 Feb (In 11 Days).
Fundamental Analysis of Tandem Diabetes Care, Inc. [TNDM]
Now let’s turn to look at profitability: with a current Operating Margin for Tandem Diabetes Care, Inc. [TNDM] sitting at -24.27 and its Gross Margin at +48.85, this company’s Net Margin is now -7.20%. These metrics indicate that this company is not generating as much profit, after accounting for expenses, compared to its market peers.
This company’s Return on Total Capital is -49.96, and its Return on Invested Capital has reached -38.10%. Its Return on Equity is -240.11, and its Return on Assets is -81.30. These metrics suggest that this Tandem Diabetes Care, Inc. does a poor job of managing its assets, and likely won’t be able to provide successful business outcomes for its investors in the near term.
What about valuation? This company’s Enterprise Value to EBITDA is -112.46. The Enterprise Value to Sales for this firm is now 13.22. Tandem Diabetes Care, Inc. [TNDM] has a Price to Book Ratio of 16.65.
Shifting the focus to workforce efficiency, Tandem Diabetes Care, Inc. [TNDM] earns $281,571 for each employee under its payroll. Similarly, this company’s Receivables Turnover is 6.57 and its Total Asset Turnover is 1.22. This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 2.53 and its Current Ratio is 2.83. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.
Tandem Diabetes Care, Inc. [TNDM] has 59.28M shares outstanding, amounting to a total market cap of $4.92B. Its stock price has been found in the range of 44.45 to 82.59. At its current price, it has moved up by 0.52% from its 52-week high, and it has moved up 86.77% from its 52-week low.
This stock’s Beta value is currently 0.11, which indicates that it is 4.39% more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 76.39. This RSI suggests that Tandem Diabetes Care, Inc. is currently Overbought.
Conclusion: Is Tandem Diabetes Care, Inc. [TNDM] a Reliable Buy?
Shares of Tandem Diabetes Care, Inc. [TNDM], overall, appear to be a solid investment option, with Wall Street analysts expecting its price to rise considerably in the next 12 months. This company generates high value from the labor resources and other capital it has available, and while it has heavy Long-Term Debt to Equity, the majority of the metrics point to this investment being highly attractive.